DEA Introduces New Rules to Expand Telemedicine Access and Safeguard Patient Care

The U.S. Drug Enforcement Administration (DEA) has announced three new telemedicine rules aimed at balancing expanded access to remote healthcare with robust patient protections. These measures, which build on temporary flexibilities introduced during the COVID-19 public health emergency, include key provisions for prescribing controlled medications via telemedicine. They also establish new safeguards to prevent misuse and ensure the safe administration of such medications.

The new regulations apply exclusively to telemedicine encounters involving patients who have not had an in-person evaluation with a medical provider and are being prescribed controlled medications. Patients who have already had an in-person visit can continue to receive medications through telemedicine indefinitely. Non-prescription telemedicine visits remain unaffected by these rules, maintaining open access to virtual healthcare for general consultations.

A significant feature of the new rules is the expanded access to buprenorphine, a medication used to treat opioid use disorder. Patients can now receive a six-month supply through telemedicine consultations, with further prescriptions requiring an in-person visit. This provision aims to address barriers to treatment while ensuring ongoing monitoring of patient care.

The DEA has also introduced a special registration system for telemedicine providers prescribing Schedule III-V controlled substances. Advanced registration options will enable qualified specialists, such as psychiatrists and hospice care physicians, to prescribe Schedule II medications via telemedicine. The agency is seeking public feedback on additional patient protections, such as limiting telemedicine-prescribed Schedule II medications and requiring providers to practice in the same state as their patients. These rules are designed to combat medication diversion and ensure compliance with a nationwide Prescription Drug Monitoring Program (PDMP).

Veterans receiving care through the U.S. Department of Veterans Affairs (VA) are exempt from the special registration requirements. VA practitioners can extend care via telemedicine without additional in-person evaluations, streamlining continuity of care for this population.

The new rules incorporate public input gathered through listening sessions and comments received during the rule-making process, with revisions made in response to more than 38,000 submissions. These efforts aim to address patient and provider concerns while advancing the DEA’s mission to balance access with safety.

Article by multiple RFHC contributors.

Video Spotlight